Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Teleflex Inc (NY: TFX )

222.63 +2.33 (+1.06%)
Official Closing Price Updated: 7:00 PM EDT, Jul 29, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 278,654
Open 220.51
Bid (Size) 89.37 (1)
Ask (Size) 229.45 (2)
Prev. Close 220.30
Today's Range 218.41 - 223.76
52wk Range 177.63 - 257.85
Shares Outstanding 46,801,138
Dividend Yield 0.61%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Teleflex Awarded Hemostasis Products Agreements with Premier, Inc.
Hemostatic Dressings and Devices are Now Available at Special Pricing for Premier Members 
From Teleflex Incorporated
Via GlobeNewswire
Teleflex Announces the Teleflex Center for Antimicrobial Protection
From Teleflex Incorporated
Via GlobeNewswire

Performance

YTD
-11.10%
-11.10%
1 Month
+5.85%
+5.85%
3 Month
+6.79%
+6.79%
6 Month
-9.87%
-9.87%
1 Year
-11.36%
-11.36%

More News

Read More
Teleflex Announces Second Quarter 2024 Earnings Conference Call Information
From Teleflex Incorporated
Via GlobeNewswire
A Glimpse Into The Expert Outlook On Teleflex Through 4 Analysts
Via Benzinga
(TFX) - Analyzing Teleflex's Short Interest
Via Benzinga
Peering Into Teleflex's Recent Short Interest
Via Benzinga
This Medical Devices Stock Has Several Catalysts, Says Bullish Analyst
Via Benzinga
Teleflex Publishes 2023 Global Impact Report
From Teleflex Incorporated
Via GlobeNewswire
Teleflex Expands Intraosseous Vascular Access Portfolio with New Arrow™ EZ-IO™ Intraosseous Access Procedure Tray
From Teleflex Incorporated
Via GlobeNewswire
Expert Ratings For Teleflex
Via Benzinga
How Is The Market Feeling About Teleflex?
Via Benzinga
(TFX) - Analyzing Teleflex's Short Interest
Via Benzinga
Teleflex: Dividend Insights
Via Benzinga
Outcomes From Two New Head-to-Head Randomized Controlled Trials Involving the UroLift™ System Highlight a Superior Patient Experience* Against Rezūm and Its Advantage Over Medical Therapy as an Early Intervention for BPH
From Teleflex Incorporated
Via GlobeNewswire
Teleflex Announces Quarterly Dividend
From Teleflex Incorporated
Via GlobeNewswire
TFX Stock Earnings: Teleflex Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
Breaking Down Teleflex: 4 Analysts Share Their Views
Via Benzinga
Teleflex Reports First Quarter Financial Results and Full Year 2024 Outlook
From Teleflex Incorporated
Via GlobeNewswire
Teleflex Announces Multiple Clinical and Real-World Evidence Studies to Be Highlighted at the 2024 American Urological Association Annual Meeting
From Teleflex Incorporated
Via GlobeNewswire
Teleflex Announces the Limited Market Release of the Wattson™ Temporary Pacing Guidewire
From Teleflex Incorporated
Via GlobeNewswire
Teleflex to Present at the BofA Securities 2024 Health Care Conference
From Teleflex Incorporated
Via GlobeNewswire
Teleflex Announces First Quarter 2024 Earnings Conference Call Information
From Teleflex Incorporated
Via GlobeNewswire
Teleflex Incorporated Introduces the UroLift™ 2 System With Advanced Tissue Control, a Revolutionary Unified Platform Designed to Treat All Prostate Types
From Teleflex Incorporated
Via GlobeNewswire
Teleflex’s Climate Targets Validated by the Science Based Targets Initiative
From Teleflex Incorporated
Via GlobeNewswire
Glancy Prongay & Murray LLP Announces Investigation of Teleflex Incorporated (TFX)
From Glancy Prongay & Murray LLP
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.